Antiparkinson Agents

"Antiparkinson Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Descriptor ID	D000978
MeSH Number(s)	D27.505.954.427.090.050
Concept/Terms	Antiparkinson Agents Antiparkinson Agents Agents, Antiparkinson Antiparkinsonian Agents Agents, Antiparkinsonian Antiparkinsonians Antiparkinson Drugs Drugs, Antiparkinson

Below are MeSH descriptors whose meaning is more general than "Antiparkinson Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Anti-Dyskinesia Agents [D27.505.954.427.090]
Antiparkinson Agents [D27.505.954.427.090.050]

Below are MeSH descriptors whose meaning is related to "Antiparkinson Agents".

Below are MeSH descriptors whose meaning is more specific than "Antiparkinson Agents".

Antiparkinson Agents
Aromatic Amino Acid Decarboxylase Inhibitors
Catechol O-Methyltransferase Inhibitors

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antiparkinson Agents" by people in this website by year, and whether "Antiparkinson Agents" was a major or minor topic of these publications.

Bar chart showing 10 publications over 9 distinct years, with a maximum of 2 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2006	0	2	2
2008	0	1	1
2010	1	0	1
2012	0	1	1
2015	0	1	1
2017	1	0	1
2021	0	1	1
2023	0	1	1

Below are the most recent publications written about "Antiparkinson Agents" by people in Profiles.

Isaacson SH, Kremens D, Torres-Yaghi Y, Stocchi F, Antonini A. Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease. Parkinsonism Relat Disord. 2023 09; 114:105495.

View in: PubMed
Chou KL, Martello J, Atem J, Elrod M, Foster ER, Freshwater K, Gunzler SA, Kim H, Mahajan A, Sarva H, Stebbins GT, Lee E, Yang L. Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update. Neurology. 2021 08 03; 97(5):239-245.

View in: PubMed
Leehey M, Luo S, Sharma S, Wills AA, Bainbridge JL, Wong PS, Simon DK, Schneider J, Zhang Y, Pérez A, Dhall R, Christine CW, Singer C, Cambi F, Boyd JT. Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. Neurology. 2017 Oct 24; 89(17):1789-1794.

View in: PubMed
Chen J, Ho SL, Lee TM, Chang RS, Pang SY, Li L. Visuomotor control in patients with Parkinson's disease. Neuropsychologia. 2016 Jan 08; 80:102-114.

View in: PubMed
Shea YF, Mok MM, Chang RS. Gabapentin-induced myoclonus in an elderly with end-stage renal failure. J Formos Med Assoc. 2014 Sep; 113(9):660-1.

View in: PubMed
Schneider JS, Elm JJ, Parashos SA, Ravina BM, Galpern WR. Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Parkinsonism Relat Disord. 2010 Sep; 16(8):507-12.

View in: PubMed
Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, Kagan N, Beyer C, Lin Q, Dwyer JM, Zaleska MM, Bowlby MR, Dunlop J, Monaghan M. Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiol Dis. 2008 Sep; 31(3):334-41.

View in: PubMed
Machado A, Rezai AR, Kopell BH, Gross RE, Sharan AD, Benabid AL. Deep brain stimulation for Parkinson's disease: surgical technique and perioperative management. Mov Disord. 2006 Jun; 21 Suppl 14:S247-58.

View in: PubMed
Shulman LM, Pretzer-Aboff I, Anderson KE, Stevenson R, Vaughan CG, Gruber-Baldini AL, Reich SG, Weiner WJ. Subjective report versus objective measurement of activities of daily living in Parkinson's disease. Mov Disord. 2006 Jun; 21(6):794-9.

View in: PubMed
Chou KL, Hurtig HI, Jaggi JL, Baltuch GH, Pelchat RJ, Weintraub D. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism Relat Disord. 2005 Sep; 11(6):403-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement